Erratum to: Cancer Immunol Immunother DOI 10.1007/s00262-007-0336-x
The original version of this article unfortunately contained a mistake. There is an error regarding the dose of BCNU utilized to treat U-87 cells—the correct concentrations are 0.28 and 2.8 μM in Fig. 5a, b. Additionally, in the “Discussion” section, the greatest CNS penetration of temozolomide and BCNU, respectively (not Gliadel), were reported as 24 ± 4 μM in the CSF [18] and 9.3 nM/gm within brain tissue [9]. The authors apologize for the error and the incorrect citation.
Footnotes
The online version of the original article can be found under doi:10.1007/s00262-007-0336-x.